We would like to keep our patients, families and professionals up to date with the latest developments in our research.
We may sometimes highlight particular “news reports” that may appear in the media, as there may be general points that are worth emphasising or challenging.
We recently expanded on our understanding of how genetic alterations in SH2B1 contribute to obesity and neurobehavioral difficulties.
Two of our young patients recently visited us to help make a short film about what it’s like to come to Cambridge and be part of our research. Check it out and meet some of our team at What happens when I come to Cambridge.
Professor Farooqi was at the University of Wolverhampton on Thursday 19 September 2019, being awarded an Honorary Doctorate of Science in recognition of her contributions to biomedical science and her longstanding connection with the Midlands.
Prof. Sadaf Farooqi has been elected as a member of EMBO, an organisation of the best researchers in Europe and around the world
Many different variants in the MC4R gene are known to lead to early onset obesity in people. Excitingly, we have now been able to demonstrate that some variants have the opposite effect and may protect people from becoming overweight.
We recently described the mechanism through which Steroid Receptor Coactivator (SRC)-1 regulates appetite and body weight.
We recently discovered why some people manage to stay thin while others gain weight.
We recently described the role of a group of neural guidance molecules, the Semaphorins in the development of hypothalamic brain circuits that regulate body weight.
This year the focus is on raising awareness of weight stigma
We recently reported the first comprehensive analysis of hypothalamic gene expression in patients with a genetic obesity syndrome.
Professor Farooqi appeared on the BBC One documentary, The Truth About Obesity, on 26th April.
The OSTRICH study seeks to identify factors that drive obesity-related complications in some young people.
In January we celebrated the 20th anniversary of the nationwide launch of the Genetics of Obesity Study (GOOS).
We report a comprehensive summary of MC4R mutations and a clinical trial in MC4R deficiency